Catalent today announced the launch of its new CTSuccess™ clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.

Catalent today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC) on Oct. 28 – 30, 2019.

Catalent today announced that Mark Woolf, its Director of Depot Networks, will present at the upcoming 6th Annual Global Clinical Supplies Group European Knowledge Forum, to be held in Cascais, Portugal, on Oct. 22 – 24, 2019.

Catalent today announced that Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.

Catalent today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia on Sept. 25 – 26, 2019.

Catalent today announced it is to invest $9 million in a new clinical supply facility in San Diego, due to open in the summer of 2020.

Catalent today announced a number of workshop presentations at the upcoming Global Clinical Supplies Group (GCSG) 2019 US Annual Conference in San Antonio, Texas.

Catalent Pharma Solutions today announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China.

Catalent Pharma Solutions today announced that three of its experts will present at two upcoming conferences, Clinical Trial Supply (CTS) Europe and CTS New England.